BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

802 related articles for article (PubMed ID: 1076826)

  • 21. Serial estimations of carbon monoxide diffusing capacity in intrapulmonary haemorrhage.
    Greening AP; Hughes JM
    Clin Sci (Lond); 1981 May; 60(5):507-12. PubMed ID: 7249536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Referential equations for pulmonary diffusing capacity generated from the Japanese population using the Lambda, Mu, or Sigma method and their comparisons with prior referential equations.
    Hanaoka M; Wada Y; Goto N; Kitaguchi Y; Koarai A; Kubota M; Oyamada Y; Koto H;
    Respir Investig; 2023 Nov; 61(6):687-697. PubMed ID: 37708634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can the measurement of pulmonary diffusing capacity for nitric oxide replace the measurement of pulmonary diffusing capacity for carbon monoxide?
    Zavorsky GS; van der Lee I
    Respir Physiol Neurobiol; 2017 Jul; 241():9-16. PubMed ID: 27884796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of the carbon monoxide diffusing capacity (DL(CO)) in relation to its KCO and VA components.
    Hughes JM; Pride NB
    Am J Respir Crit Care Med; 2012 Jul; 186(2):132-9. PubMed ID: 22538804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary diffusing capacity measured by NO/CO transfer in Tunisian boys.
    Dridi R; Dridi N; Ben Moussa Zouita A; Muller PT; Tabka Z; Guénard H; Laher I; Hackney AC; Zouhal H
    Pediatr Pulmonol; 2020 Oct; 55(10):2754-2761. PubMed ID: 32716127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fractional carbon monoxide uptake and "diffusing capacity" in models of pulmonary maldistribution.
    Harris EA; Whitlock RM
    Bull Eur Physiopathol Respir; 1983; 19(5):427-32. PubMed ID: 6640162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reference equations for the single-breath diffusing capacity. A cross-sectional analysis and effect of body size and age.
    Paoletti P; Viegi G; Pistelli G; Di Pede F; Fazzi P; Polato R; Saetta M; Zambon R; Carli G; Giuntini C
    Am Rev Respir Dis; 1985 Oct; 132(4):806-13. PubMed ID: 3876793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume.
    Johnson DC
    Respir Med; 2000 Jan; 94(1):28-37. PubMed ID: 10714476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbon monoxide diffusing capacity, other indices of lung function, and respiratory symptoms in a general population sample.
    Viegi G; Paoletti P; Prediletto R; Di Pede F; Carrozzi L; Carmignani G; Mammini U; Lebowitz MD; Giuntini C
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):1033-9. PubMed ID: 2327637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonuniformity of diffusing capacity from small alveolar gas samples is increased in smokers.
    Cotton DJ; Mink JT; Graham BL
    Can Respir J; 1998; 5(2):101-8. PubMed ID: 9707452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The single-breath diffusing capacity of CO and NO in healthy children of European descent.
    Thomas A; Hanel B; Marott JL; Buchvald F; Mortensen J; Nielsen KG
    PLoS One; 2014; 9(12):e113177. PubMed ID: 25514246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor).
    Neder JA; Andreoni S; Peres C; Nery LE
    Braz J Med Biol Res; 1999 Jun; 32(6):729-37. PubMed ID: 10412551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung function abnormalities in different connective tissue diseases.
    Vitali C; Viegi G; Tassoni S; Tavoni A; Paoletti P; Bibolotti E; Ferri C; Bombardieri S
    Clin Rheumatol; 1986 Jun; 5(2):181-8. PubMed ID: 3731715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pulmonary diffusing capacity in normal smoking Chinese].
    Yang SC
    J Formos Med Assoc; 1993 Jun; 92 Suppl 2():S61-8. PubMed ID: 7904198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gas exchange at a given degree of volume restriction is different in sarcoidosis and idiopathic pulmonary fibrosis.
    Dunn TL; Watters LC; Hendrix C; Cherniack RM; Schwarz MI; King TE
    Am J Med; 1988 Aug; 85(2):221-4. PubMed ID: 3135751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary dysfunction in systemic lupus erythematosus without pulmonary symptoms.
    Chick TW; DeHoratius RJ; Skipper BE; Messner RP
    J Rheumatol; 1976 Sep; 3(3):262-8. PubMed ID: 1086364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfer factor (diffusing capacity) standardized for alveolar volume: validation, reference values and applications of a new linear model to replace KCO (TL/VA).
    Chinn DJ; Cotes JE; Flowers R; Marks AM; Reed JW
    Eur Respir J; 1996 Jun; 9(6):1269-77. PubMed ID: 8804948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclinical pulmonary abnormalities in childhood-onset systemic lupus erythematosus patients.
    Veiga CS; Coutinho DS; Nakaie CM; Campos LM; Suzuki L; Cunha MT; Leone C; Silva CA; Rodrigues JC
    Lupus; 2016 May; 25(6):645-51. PubMed ID: 26849883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of pulmonary function in patients with systemic lupus erythematosus, scleroderma, and rheumatoid arthritis.
    Huang CT; Lyons HA
    Am Rev Respir Dis; 1966 Jun; 93(6):865-75. PubMed ID: 5942234
    [No Abstract]   [Full Text] [Related]  

  • 40. Diffusing capacity dependent on lung volume and age in normal subjects.
    Stam H; Hrachovina V; Stijnen T; Versprille A
    J Appl Physiol (1985); 1994 Jun; 76(6):2356-63. PubMed ID: 7928858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.